This trial is evaluating whether Deprescribing will improve 2 primary outcomes and 4 secondary outcomes in patients with Sleeplessness. Measurement will happen over the course of baseline (T0; week 0), post-treatment (T1; week 12), 3 month follow-up (T2; week 24).
This trial requires 50 total participants across 1 different treatment group
This trial involves a single treatment. Deprescribing is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
"Among an adult population, approximately 16.0% to 20.5% report getting sleeplessness a year. The strongest factors for reporting sleeplessness were being female and young. For patients who report sleeplessness, insomnia, fatigue, or feeling tired as the main complaint, the need for sleep, or fatigue and feeling tired all contributed significantly to a poor sleep quality or quantity." - Anonymous Online Contributor
"Sleep quality is related to psychological factors, including stress, and psychosocial factors, including social deprivation. Sleep quality may also be influenced by circadian rhythms, circadian disruption, and sleep hygiene." - Anonymous Online Contributor
"Sleeplessness has not been found to be a treatable condition. Therefore, therapy for sleeplessness should focus on reducing the cause.\nquestion: Can a person be cured? answer: When people were given the task to cure themselves of insomnia, most refused or could not complete the task. While the desire to cure oneself of insomnia may be strong, it seems impossible to permanently curb that desire." - Anonymous Online Contributor
"Sleeplessness is treated by a variety of medications. These medications include sedative-hypnotics and anticholinergic agents. Medications used for sleep maintenance can include prescription sleep aids, melatonin, and non-benzodiazepine z-drugs (e.g., zolpidem). Many patients rely on a combination of pharmacotherapy as well as CBT to improve their sleep. Patients in remission are better able to sleep at sleep onset. Cognitive behavioral therapy may also improve somnolence in some patients, even in patients on chronic medications." - Anonymous Online Contributor
"Sleeping for long hours without rest may be a predictor of future morbidity in children and adolescents. In addition, sleeping a smaller amount of time in comparison to other people of the same age could be a disadvantage. In order to know whether a condition is caused by a sleeping or a sleeping behavior, a doctor or psychologist could help you to see the sleeping pattern on a sleep history for more than 2 months. A doctor or psychologist may also help you to find a sleep disorder by making sure your sleeping habits have no correlation with your medical conditions. Also, the type of sleep disorder includes narcolepsy, sleep apnea, hypersomnia, or restless sleep." - Anonymous Online Contributor
"Recent findings shows that insomnia is a common sleep problem in patients with asthma and that insomnia is frequently associated with depressed mood. Sleeplessness should be considered a possible symptom and treated because it may be treatable." - Anonymous Online Contributor
"The evidence from this review suggests the existence of significant gaps in our knowledge about the underlying mechanisms of sleep in both disease and in normal wakefulness." - Anonymous Online Contributor
"While a small percentage of people did not report that they did not forget to take their medication, this information could help doctors and patients remember to take their medication." - Anonymous Online Contributor
"These patients are living with chronic and recurrent pain and other problems that do not improve with medications. The doctors are prescribing treatments based on patients' previous experiences or expectations of treatment, without having a clear definition of what deprescribing entails. A better understanding of patient perceptions and expectations in this group of patients may aid physicians in making better medical decisions." - Anonymous Online Contributor
"Deprescribing usually treats the conditions for which patients have been on the medications. A few patients did not receive a therapeutic dose and had no change in clinical status or adverse events. It is crucial that prescribers monitor patients on drugs commonly de-prescribed." - Anonymous Online Contributor
"Overall, patients with insomnia have greater insomnia symptoms and more adverse consequences, perhaps because their sleep is interrupted and their wake times are irregular. These data raise concerns about the long-term consequences of insomnia." - Anonymous Online Contributor
"This article focuses on new research developments in the deprescribing of antidepressants in older people. Many older adults live with depressive symptoms and chronic illnesses, which may worsen their health-related quality of life. Current clinical guidelines provide evidence-based assessments. Clinicians can then decide to deprescribe based on the patient's preferences and the patient's goals of care." - Anonymous Online Contributor